Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R

被引:15
作者
Zhang, Zuojun [1 ]
Zhao, Ming [1 ]
Wang, Guojie [1 ]
机构
[1] Luoyang Orthoped Hosp Henan Prov, Upper Limb Injury Treatment Ctr, Orthoped Hosp Henan Prov, Luoyang 471002, Peoples R China
关键词
growth; IGF1R; invasion; lung metastasis; metastasis; microRNA-7; osteosarcoma; promoter methylation; FACTOR RECEPTOR; TUMOR-SUPPRESSOR; MIGRATION; INSULIN; PROLIFERATION; EXPRESSION; INVASION; CANCER; APOPTOSIS;
D O I
10.1002/jcp.28787
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We aim to uncover the methylation of microRNA-7 (miR-7) promoter in osteosarcoma (OS) and the inner mechanism of miR-7 on the progression of OS cells. Expression and methylation state of miR-7 in OS tissues and cells were detected. With the aim to unearth the ability of miR-7 in OS, the proliferation, cell cycle progression, apoptosis, invasion, migration of OS cells, and the tumor growth in nude mice were determined. Meanwhile, IGF1R expression was detected and the association between miR-7 and IGF1R was confirmed. The proliferating cell nuclear antigen (PCNA) expression was tested by immunohistochemical staining, and the lung metastasis was observed by H&E staining. miR-7 expression was decreased and methylation state of miR-7 was increased in OS tissues and cells. Upregulated miR-7 inhibited proliferation, cell cycle progression, invasion,and migration, while inducing apoptosis of OS cells and the tumor growth as well as PCNA expression in nude mice. Expression of IGF1R was downregulated in OS cells with overexpression of miR-7. Experiments verified the binding site between miR-7 and IGF1R. Our study demonstrates that abnormal methylation of miR-7 contributes to decreased miR-7 in OS. In addition, miR-7 represses the initiation and progression of OS cells through the inhibition of IGF1R.
引用
收藏
页码:22195 / 22206
页数:12
相关论文
共 40 条
[1]   Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand? [J].
Anninga, Jakob K. ;
Gelderblom, Hans ;
Fiocco, Marta ;
Kroep, Judith R. ;
Taminiau, Anstoni H. M. ;
Hogendoorn, Pancras C. W. ;
Egeler, R. Maarten .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (16) :2431-2445
[2]   MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma [J].
Bi, Yiliang ;
Shen, Wei ;
Min, Min ;
Liu, Yan .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 39 (04) :900-906
[3]   Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4 [J].
Chen, Bin ;
Bao, Yongzheng ;
Chen, Xiaoming ;
Yi, Jiping ;
Liu, Sheting ;
Fang, Zuozhong ;
Zheng, Shuai ;
Chen, Jianting .
BIOMEDICINE & PHARMACOTHERAPY, 2015, 75 :1-7
[4]   MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1 [J].
Cheng, Dong-dong ;
Yu, Tao ;
Hu, Tu ;
Yao, Ming ;
Fan, Cun-yi ;
Yang, Qing-cheng .
ONCOTARGET, 2015, 6 (40) :42761-42772
[5]   Chemotherapy resistance in osteosarcoma: current challenges and future directions [J].
Chou, Alexander J. ;
Gorlick, Richard .
EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (07) :1075-1085
[6]   Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines [J].
Duan, Zhenfeng ;
Choy, Edwin ;
Harmon, David ;
Yang, Cao ;
Ryu, Keinosuke ;
Schwab, Joseph ;
Mankin, Henry ;
Hornicek, Francis J. .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (08) :2122-2130
[7]  
Fuchs B, 2002, CLIN ORTHOP RELAT R, P40
[8]   miRNA-7-5p inhibits melanoma cell migration and invasion [J].
Giles, Keith M. ;
Brown, Rikki A. M. ;
Epis, Michael R. ;
Kalinowski, Felicity C. ;
Leedman, Peter J. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 430 (02) :706-710
[9]   Osteosarcoma [J].
Gorlick, Richard ;
Khanna, Chand .
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (04) :683-691
[10]   The molecular mechanisms and therapeutic potential of microRNA-7 in cancer [J].
Gu, Dian-Na ;
Huang, Qian ;
Tian, Ling .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (03) :415-426